Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

A normal response to Synachten test does not rule out corticosteroid effectiveness in weaning from catecholamine after septic shock.

Cavaliere F, Craba A, Caputo C, Gaspari R, Conti G, Proietti R.

Minerva Anestesiol. 2007 Jun;73(6):367-70.

2.

Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.

de Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB.

Crit Care Med. 2007 Aug;35(8):1896-903.

PMID:
17568326
3.

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.

Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace.

PMID:
19237882
4.

[Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].

Fellahi JL, Bénard P, Daccache G, Mourgeon E, Gérard JL.

Ann Fr Anesth Reanim. 2003 Jul;22(7):631-4. French.

PMID:
12946495
5.

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.

Crit Care Med. 2008 Jan;36(1):296-327. Erratum in: Crit Care Med. 2008 Apr;36(4):1394-6.

PMID:
18158437
6.

Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.

Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, Pietropaoli P, Westphal M.

Shock. 2007 Nov;28(5):530-5.

PMID:
17589379
7.

Dear vasopressin, where is your place in septic shock?

Duenser MW, Hasibeder WR.

Crit Care. 2005 Apr;9(2):134-5. Epub 2004 Nov 15.

8.

Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy.

Morel J, Venet C, Donati Y, Charier D, Liotier J, Frere-Meunier D, Guyomarc'h S, Diconne E, Bertrand JC, Souweine B, Papazian L, Zeni F.

Intensive Care Med. 2006 Aug;32(8):1184-90. Epub 2006 Jun 20.

PMID:
16786331
9.

Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients.

Fuchs PCh, Bozkurt A, Johnen D, Smeets R, Groger A, Pallua N.

Burns. 2007 May;33(3):306-11.

PMID:
17382191
10.

Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality.

Boyer A, Chadda K, Salah A, Annane D.

Int J Clin Pharmacol Ther. 2006 Jul;44(7):309-18. Review.

PMID:
16961159
11.

Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic.

Merouani M, Guignard B, Vincent F, Borron SW, Karoubi P, Fosse JP, Cohen Y, Clec'h C, Vicaut E, Marbeuf-Gueye C, Lapostolle F, Adnet F.

Crit Care. 2008;12(6):R155. doi: 10.1186/cc7149. Epub 2008 Dec 9.

12.

Adrenal function in sepsis and septic shock.

Pizarro CF, Troster EJ.

J Pediatr (Rio J). 2007 Nov;83(5 Suppl):S155-62. Epub 2007 Nov 7. Review.

13.
14.

New evidence for old therapies in catecholamine-dependent septic shock.

Friedrich JO, Lapinsky SE.

Intensive Care Med. 2001 Apr;27(4):787-90. Review. No abstract available.

PMID:
11398711
15.

Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.

Bauer SR, Lam SW, Cha SS, Oyen LJ.

J Crit Care. 2008 Dec;23(4):500-6. doi: 10.1016/j.jcrc.2008.04.002. Epub 2008 Jun 30.

PMID:
19056013
16.

Refractory septic shock: efficacy and safety of very high doses of norepinephrine.

Katsaragakis S, Kapralou A, Theodorou D, Markogiannakis H, Larentzakis A, Stamou KM, Drimousis P, Bramis I.

Methods Find Exp Clin Pharmacol. 2006 Jun;28(5):307-13.

PMID:
16845448
17.

Septic shock--vasopressin, norepinephrine, and urgency.

Parrillo JE.

N Engl J Med. 2008 Feb 28;358(9):954-6. doi: 10.1056/NEJMe0800245. No abstract available.

PMID:
18305271
18.

Use of heptaminol hydrochloride for catecholamine weaning in septic shock.

Bahloul M, Chaari A, Ben Mbarek MN, Kallel H, Bouaziz M.

Am J Ther. 2012 Jan;19(1):e8-17. doi: 10.1097/MJT.0b013e3181e9b630.

PMID:
20720484
19.

The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock.

Goodman S, Sprung CL; International Sepsis Forum.

Crit Care. 2002 Oct;6(5):381-3. Epub 2002 Jul 17. Review.

20.

Corticosteroid insufficiency in acutely ill patients.

Bloomfield R, MacMillan M, Noble DW.

N Engl J Med. 2003 May 22;348(21):2157-9. No abstract available.

PMID:
12765169
Items per page

Supplemental Content

Write to the Help Desk